Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled

Cencora Inc (COR) stock closed down by 5.92% on August 12, primarily due to the confirmed transition of non-prime Walgreens pharmaceutical volume to competitors. Despite management reiterating full-year earnings per share guidance, investors focused on potential revenue risks and customer retention challenges in the competitive pharmaceutical distribution market. The company also faces headwinds from subdued revenue guidance, rising interest expenses, and asset impairments, overshadowing its industry-leading annual revenue of $321.33 billion.